Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

June 29, 2017

Patient Enrollment Paused in Phase 3 Trial of Tedopi in NSCLC

News

OSE Immunotherapeutics has temporarily paused patient enrollment in a Phase 3 clinical trial evaluating Tedopi (OSE2101) for non-small cell lung cancer (NSCLC), following a recommendation by an Independent Data Monitoring ... Read more

April 4, 2017

Screening Initiative in Georgia Finds Twice the Lung Cancer Rate of Previous Efforts

News

A pioneering lung cancer screening initiative in the Augusta, Ga., area found more than double the rate of cancer observed in previous studies. An analysis of the data collected points toward the need ... Read more

March 28, 2017

Mobile Unit Begins Lung Cancer Screening in Rural Areas of Carolinas

News

The Carolinas HealthCare System‘s Levine Cancer Institute has dispatched a mobile lung computed tomography (CT) unit to rural areas of North and South Carolina to diagnose lung cancer. The hope is that ... Read more

March 16, 2017March 16, 2017

Get Screened or Not? Counseling, Professional Consultations Help People at High Risk Decide

News

Structured pre-screening counseling and shared decision-making visits with healthcare professionals help patients assess the benefits and risks of yearly lung cancer screening, according to a new study published in CHEST. Lung ... Read more

February 10, 2017

Fewer than 4% of High-Risk Current and Former Smokers Get Screened for Lung Cancer, Study Finds

News

Despite recommendations that high-risk current and former smokers be more frequently screened, lung cancer screening rates remained unchanged and very low among eligible patients in 2015, says new research showing that ... Read more

January 12, 2017

Pioneering Clinical Trial Successfully Controls Patient’s Advanced Lung Cancer

News

A pioneering Phase 1/2 clinical trial has successfully controlled a patient’s advanced lung cancer using a combination of two immunotherapy drugs. The ECHO-202 trial (NCT02178722) is being conducted at 20 ... Read more

November 14, 2016November 29, 2016

ARIAD Launches Inaugural ALK-positive NSCLC Awareness Day

News

ARIAD Pharmaceuticals recently launched an awareness day for anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC), the first time a day was specifically focused on the condition. The ... Read more

March 28, 2016May 17, 2016

Early Lung Cancer Detection Researcher Granted Foundation’s First-Ever Award of $300,000

News

A first-time foundation grant of $300,000 was awarded to Robin Mjelle, Ph.D., for his innovative work in the identification, characterization and validation of lung cancer early detection biomarkers. Mjelle is a scientist at the Norwegian ... Read more

March 5, 2016May 17, 2016

Additional Lung Cancer Research Added to Project Data Sphere Library-Laboratory

News

Project Data Sphere, an autonomous nonprofit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium, LSC, has just added additional lung cancer clinical trial data to its Project Data Sphere platform ... Read more

January 24, 2016May 17, 2016

Lung Cancer Clinical Trial to Test New Combo of Immunotherapy Drugs in People with Advanced Disease

News

A clinical trial led by researchers at the Medical University of South Carolina (MUSC) will test a new combination of two immunotherapy drugs in people with non-small cell lung cancer (NSCLC) — the ... Read more